Abacavir, dolutegravir, and lamivudine and Cardiovascular disease
Result of checking the interaction of drug Abacavir, dolutegravir, and lamivudine and disease Cardiovascular disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Some clinical trials have reported increased risk of myocardial infarction in patients treated with abacavir. Although some of the findings are inconclusive, as a precaution, the underlying risk of coronary heart disease should be assessed before therapy, and action should be taken to minimize all modifiable risk factors such as hypertension, hyperlipidemia, diabetes mellitus, smoking, etc.
Generic Name: abacavir / dolutegravir / lamivudine
Brand Name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Abacavir, dolutegravir, and lamivudine - choroba sercowo-naczyniowa 
Abacavir, dolutegravir, and lamivudine - doença cardiovascular 
Abacavir, dolutegravir, and lamivudine - penyakit kardiovaskular 
Abacavir, dolutegravir, and lamivudine - penyakit kardiovaskular 
Abacavir, dolutegravir, and lamivudine - malattia cardiovascolare 
Abacavir, dolutegravir, and lamivudine - maladie cardiovasculaire 
Abacavir, dolutegravir, and lamivudine - Herzkreislauferkrankung 
Abacavir, dolutegravir, and lamivudine - enfermedad cardiovascular 
Abacavir, dolutegravir, and lamivudine - сердечно-сосудистые заболевания 
Abacavir, dolutegravir, and lamivudine - kalp-damar hastalığı 
Abacavir, dolutegravir, and lamivudine - أمراض القلب والأوعية الدموية 
Abacavir, dolutegravir, and lamivudine - 心血管疾病